Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1423, 2004-01, pp. : 6-6
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Histrelin acetate implant beneficial for advanced prostate cancer
Inpharma, Vol. 1, Iss. 1537, 2006-01 ,pp. :
Access to resources
Recommend
Switch to exemestane beneficial in early breast cancer
Inpharma, Vol. 1, Iss. 1617, 2007-01 ,pp. :
Vinorelbine + doxorubicin divided schedule beneficial in breast cancer
Inpharma, Vol. 1, Iss. 1282, 2001-01 ,pp. :
Switch to exemestane beneficial in early breast cancer
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 543, 2007-01 ,pp. :
Tipifarnib promising in advanced breast cancer
Inpharma, Vol. 1, Iss. 1402, 2003-01 ,pp. :